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Abstract 
In this paper, we apply model predictive control (MPC) for control of blood glucose in 
people with type 1 diabetes. The two first control strategies are based on nonlinear 
model predictive control (NMPC). The first control strategy is based on meal 
announcement in advance, while the second one considers meal announcement at 
mealtimes only. They give a quantitative upper bound on the achievable control 
performance. The third control strategy is a feedforward-feedback control strategy. This 
strategy uses a time-varying setpoint to reduce the risk of hypoglycemia. The feedback 
controller computes the optimal basal insulin infusion rate. The feedforward controller 
consists of a bolus calculator. It computes the optimal bolus, along with the time-
varying glucose setpoint. We test these three strategies on a virtual patient with type 1 
diabetes. The numerical results demonstrate the robustness of the last control strategy 
with respect to changes in the model parameters and incorrect meal announcement. 
 
Keywords: Type 1 diabetes, Nonlinear model predictive control, feedforward-feedback 
control 
1. Introduction 
The World Health Organization (WHO) estimates that more than 220 million people 
worldwide have diabetes. This number is likely to double by 2030. In the USA, the 
budget for diabetes represents 10% of the health care budget, i.e. more than 130 billion 
dollars (132 billion dollars in 2002). 
In people without diabetes, the blood glucose is controlled tightly around 90 mg/dL (5 
mmol/L). Type 1 diabetes is a chronic disease characterized by an insufficient 
(effectively nonexistent) endogenous production of insulin, which leads to poor 
regulation of glucose concentrations in the blood. In particular, the deficiency of insulin 
causes sustained high glucose levels (hyperglycemia) that result in serious long-term 
health problems like eye, nerve, and kidney disease. On the other hand, too much 
insulin can result in very low glucose levels (hypoglycemia) which can pose immediate 
health risks. Consequently, exogenous insulin must be injected to regulate the blood 
glucose concentration as tightly as possible. 
Usually, insulin treatment consists of the administration of rapid acting insulin through 
boluses (i.e., discrete insulin administration) at the time of meals. The size of the bolus 
is based on a measurement of the current blood glucose at mealtime and the (estimated) 
size of the meal. However, having measurements only at mealtime does not provide 
enough information about blood glucose. Consequently, people with diabetes often 
tolerate hyperglycemia in order to avoid hypoglycemia and its immediate effects. 
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Continuous glucose monitors (CGM) can help to provide a better control of blood 
glucose. They measure the glucose concentration in the subcutaneous depot. Insulin 
pumps that continuously inject fast acting insulin have also been developed. Combining 
a CGM with an insulin pump can enable automatic insulin administration for people 
with type 1 diabetes. Such a medical device is called an artificial pancreas, and its 
principle is illustrated in Fig. 1. Several research groups work on aspects of control 
algorithms integrating the CGM and the insulin pump to automatically adjust insulin 
administration for people with type 1 diabetes, such as Cobelli et al. (2009) and Klonoff 
et al. (2009). 
In this paper we use the model developed by Hovorka et al. (2004) and described in 
Boiroux et al. (2010b) to simulate a patient with type 1 diabetes. In the Hovorka model, 
the quality of the glucose control is limited by the time lag associated with 
subcutaneous-to-intravenous insulin absorption. This system property fundamentally 
limits the control quality that can be achieved in closed-loop insulin administration, as 
demonstrated in Boiroux et al. (2010a). 
2. Nonlinear Model Predictive Control 
In this section, we state the continuous-time optimal control problem and apply it to the 
computation of the optimal insulin profiles for people with type 1 diabetes. The optimal 
insulin administration is formulated as a bound constrained continuous-time Bolza 
problem  
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in which xntx R)(  is the state vector, untu R)(   is the vector of manipulated inputs 
(insulin injection), and dntd R)(  is the vector of known disturbances (meals). We 
assume the state vector x(t) and the input vector u(t) to be constant between the 
sampling times and a constant sampling time 5sT min. Thus, we can use the multiple-
Fig. 1. Closed-loop glucose control. Glucose is measured subcutaneously using a continuous 
glucose monitor (CGM). Insulin is dosed either continuously by an insulin pump or discretely 
using an insulin pen 
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shooting based algorithm described in Boiroux et al. (2009a) to solve the nonlinear 
program (1). 
In the scenario considered, the simulated 70 kg subject has a 62 g CHO meal at 6:00, a 
55 g CHO meal at 12:00, and a 50 g CHO meal at 18:00. Fig. 2 illustrates an optimal 
insulin administration profile for the described scenario in the case where the controller 
knows the size and time of all meals in advance. Knowing the meal times and sizes 
allows the controller to deliver anticipatory insulin to avoid postprandial 
hyperglycaemia. However, the assumption that the patient would know in advance - and 
with accuracy - the meal times and sizes is not practical. Safety considerations would 
preclude significant amounts of insulin from being delivered prior to mealtime (as in 
this ideal scenario). 
Fig. 3 shows the simulation results for the case in which the meals are announced to the 
MPC only at mealtime. Thus, the controller can deliver no anticipatory insulin prior to 
meals. The limitations for this case force the subject into (mild) hyperglycaemia, but 
hypoglycaemia is avoided. The insulin delivery profile for this case looks quite similar 
to bolus delivery of insulin by a pen; most of the meal-related insulin is delivered in 
bolus form in the few samples after the meals are taken (and announced). 
3. Bolus calculator and control 
In this section we describe an offset-free feedforward-feedback controller to compute 
optimal insulin profiles. Garcia-Gabin et al (2008) and Marchetti et al. (2008) 
established that a time-varying glucose setpoint can reduce the risk of hypoglycemia. 
The feedforward controller consists of a bolus calculator. It computes the optimal bolus 
size and the glucose setpoint, based on the meal size announced by the patient. The 
feedback controller adjusts the basal insulin infusion rate to compensate for mismatches 
in meal announcement and variations in the physiological parameters of the patient. The 
calculation of the basal insulin is based on a linear MPC algorithm. 
We use the Hovorka model and the offset-free linear MPC algorithm developed in 
Boiroux et al. (2011) to compute the optimal insulin administration profiles for people 
with type 1 diabetes. In the scenario considered, the glucose sensor provides a signal 
perturbated by a normally distributed white noise. We consider two cases. In the first 
case, we decrease the insulin sensitivity by 50% under fasting conditions. In the second 
Fig. 2. Glucose profile (top), meal disturbances 
profile (middle) and insulin administration 
profile with meal announcement in advance. 
Fig. 3. Glucose profile (top), meal disturbances 
profile (middle) and insulin administration 
profile with meal announcement at mealtime. 
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case, the patient has one 75g CHO meal 6 hours after the beginning of the simulation. In 
the case where the patient has a meal, we consider the cases where the correct meal size 
is announced, the meal size is underestimated by 50% and the meal size is 
overestimated by 50%. 
Fig. 4 illustrates the blood glucose and the insulin profiles in the case where a change in 
the insulin sensitivity occurs while the patient is fasting, with sensor noise. The insulin 
infusion rate increases to reject the disturbance caused by the decrease in insulin 
sensitivity. In the uncontrolled case where the basal insulin infusion rate is not adjusted, 
the blood glucose tends to a new steady state in the hyperglycemic range. 
For the case where the exact meal size is announced (Fig. 5), the insulin infusion rate 
remains close to the basal rate. Consequently, the blood glucose follows tightly the 
glucose setpoint. For the case where the meal size is underestimated (Fig. 6), the basal 
rate increases after the mealtime to compensate for the too low bolus. For the case 
where the meal size is overestimated (Fig. 7), the insulin infusion rate is at the minimum 
after the meal to compensate for the too high bolus. No hypoglycemic events occur 
when a meal is announced. However, the postprandial blood glucose excursion is bigger 
when the meal size is underestimated by the patient. 
These results show that reasonably good control can be obtained when a feedforward-
feedback strategy is used, even for uncertain systems. However, the main limitation of 
this strategy is that a fairly good nonlinear model description of the patient must be 
available. 
4. Conclusion 
In this paper we applied nonlinear model predictive control to compute the optimal 
insulin profiles for people with type 1 diabetes. These profiles give an upper-bound on 
the maximal achievable performance in the cases where the meals are announced 
beforehand, and in the case where meals are announced at mealtimes only. We utilized 
the bolus-like nature of the optimal insulin profile to design an offset-free feedforward-
feedback controller. The feedforward part is a model-based bolus calculator, while the 
Fig. 5. Blood glucose (top) and insulin 
administration (bottom) profile in the case where 
the right meal size is announced 
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Fig. 4. and insulin administration (bottom) 
profile in the case wherethe insulin sensitivity 
decreases by 50% after 1 hour. 
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feedback part adjusts the basal insulin infusion rate. The numerical results demonstrate 
that a rather good control of blood glucose can be obtained, assuming that a fairly good 
physiological model of the patient can be identified. 
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Fig. 6. Blood glucose profile(top) and insulin 
profile (bottom). Meal size underestimated by 
50%. 
Fig. 7. Blood glucose profile(top) and insulin 
profile (bottom). Meal size overestimated by 
50%. 
